Fetal cardiac effects of maternal hyperglycemia during pregnancy
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Maternal diabetes mellitus is associated with increased teratogenesis, which can occur in pregestational type 1 and type 2 diabetes. Cardiac defects and with neural tube defects are the most common malformations observed in fetuses of pregestational diabetic mothers. The exact mechanism by which diabetes exerts its teratogenic effects and induces embryonic malformations is unclear. Whereas the sequelae of maternal pregestational diabetes, such as modulating insulin levels, altered fat levels, and increased reactive oxygen species, may play a role in fetal damage during diabetic pregnancy, hyperglycemia is thought to be the primary teratogen, causing particularly adverse effects on cardiovascular development. Fetal cardiac defects are associated with raised maternal glycosylated hemoglobin levels and are up to five times more likely in infants of mothers with pregestational diabetes compared with those without diabetes. The resulting anomalies are varied and include transposition of the great arteries, mitral and pulmonary atresia, double outlet of the right ventricle, tetralogy of Fallot, and fetal cardiomyopathy. A wide variety of rodent models have been used to study diabetic teratogenesis. Both genetic and chemically induced models of type 1 and 2 diabetes have been used to examine the effects of hyperglycemia on fetal development. Factors such as genetic background as well as confounding variables such as obesity appear to influence the severity of fetal abnormalities in mice. In this review, we will summarize recent data on fetal cardiac effects from human pregestational diabetic mothers, as well as the most relevant findings in rodent models of diabetic cardiac teratogenesis. Birth Defects Research (Part A), 2009. © 2009 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lawrence, J. M., Contreras, R., Chen, W., & Sacks, D. A. (2008) · Diabetes Care · doi:10.2337/dc07-2345 · Cited by 658
The NOD mouse model of type 1 diabetes: As good as it gets?
Atkinson, M. A., & Leiter, E. H. (1999) · Nature Medicine · doi:10.1038/9442 · Cited by 588
Fetal and neonatal outcomes of diabetic pregnancies
Yang, J., Cummings, E. A., OʼConnell, C., & Jangaard, K. (2006) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000231688.08263.47 · Cited by 352
Maternal diabetic control and hypertrophic cardiomyopathy in infants of diabetic mothers
Sheehan, P. Q., Rowland, T. W., Shah, B. L., McGravey, V. J., & Reiter, E. O. (1986) · Clinical Pediatrics · doi:10.1177/000992288602500507 · Cited by 72
Cited by
Early Developmental Conditioning of Later Health and Disease: Physiology or Pathophysiology?
Hanson, M. A., & Gluckman, P. D. (2014) · Physiological Reviews · doi:10.1152/physrev.00029.2013 · Cited by 1,188
Metabolic Coordination of Physiological and Pathological Cardiac Remodeling
Gibb, A. A., & Hill, B. G. (2018) · Circulation Research · doi:10.1161/circresaha.118.312017 · Cited by 387
Preconception care for women with diabetes and prevention of major congenital malformations
Kitzmiller, J. L., Wallerstein, R., Correa, A., & Kwan, S. (2010) · Birth Defects Research Part A: Clinical and Molecular Teratology · doi:10.1002/bdra.20734 · Cited by 369
Ornoy, A., Becker, M., Weinstein-Fudim, L., & Ergaz, Z. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062965 · Cited by 339
Maternal obesity during pregnancy and cardiovascular development and disease in the offspring
Gaillard, R. (2015) · European Journal of Epidemiology · doi:10.1007/s10654-015-0085-7 · Cited by 322
“It has been suggested that excessive maternal nutrition to the developing fetus, especially hyperglycemia, may lead to teratogenicity in the first trimester of pregnancy [104, 105].”
BackgroundOrnoy, A., Reece, E. A., Pavlinkova, G., Kappen, C., & Miller, R. K. (2015) · Birth Defects Research Part C: Embryo Today: Reviews · doi:10.1002/bdrc.21090 · Cited by 313
Wahabi, H. A., Alzeidan, R. A., Bawazeer, G. A., Alansari, L. A., & Esmaeil, S. A. (2010) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-10-63 · Cited by 228
“Maternal hyperglycemia during the period of organogenesis is known to be associated with congenital malformations [39,40].”
BackgroundLorenzo-Almorós, A., Hang, T., Peiró, C., Soriano-Guillén, L., Egido, J., Tuñón, J., & Lorenzo, Ó. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0935-9 · Cited by 202
Wahabi, H. A., Alzeidan, R. A., & Esmaeil, S. A. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-792 · Cited by 126
“During the period of organogenesis, maternal hyperglycemia is known to be associated with CM [34,40].”
Background
Metadata
- Authors
- Corrigan, N., Brazil, D. P., & McAuliffe, F.
- Venue
- Birth Defects Research Part A: Clinical and Molecular Teratology
- Publisher
- Wiley
- Published
- 2009-01-29
- Volume
- 85
- Issue
- 6
- Pages
- 523-530
- ISSN
- 1542-0752 (ISSN-L)
- 1542-0760
- OpenAlex
- W1992957800
- Cited by
- 135
- References
- 4
- FWCI
- 9.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.